Form 8-K - Current report:
SEC Accession No. 0001683168-21-000064
Filing Date
2021-01-08
Accepted
2021-01-08 16:05:09
Documents
2
Period of Report
2021-01-04
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K sonoma_8k.htm 8-K 28890
2 ADDENDUM TO EMPLOYMENT AGREEMENT sonoma_ex1001.htm EX-10.1 66563
  Complete submission text file 0001683168-21-000064.txt   96769
Mailing Address 645 MOLLY LANE, SUITE 150 WOODSTOCK GA 30189
Business Address 645 MOLLY LANE, SUITE 150 WOODSTOCK GA 30189 800-759-9305
Sonoma Pharmaceuticals, Inc. (Filer) CIK: 0001367083 (see all company filings)

EIN.: 680423298 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-33216 | Film No.: 21517510
SIC: 2834 Pharmaceutical Preparations